Accendra Health Inc
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. The company also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, a… Read more
Accendra Health Inc (ACH) - Net Assets
Latest net assets as of September 2025: $-429.51 Million USD
Based on the latest financial reports, Accendra Health Inc (ACH) has net assets worth $-429.51 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.04 Billion) and total liabilities ($4.47 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-429.51 Million |
| % of Total Assets | -10.64% |
| Annual Growth Rate | 7.32% |
| 5-Year Change | -20.62% |
| 10-Year Change | -43.06% |
| Growth Volatility | 24.35 |
Accendra Health Inc - Net Assets Trend (1985–2024)
This chart illustrates how Accendra Health Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Accendra Health Inc (1985–2024)
The table below shows the annual net assets of Accendra Health Inc from 1985 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $565.23 Million | -38.84% |
| 2023-12-31 | $924.17 Million | -2.27% |
| 2022-12-31 | $945.60 Million | +0.76% |
| 2021-12-31 | $938.50 Million | +31.80% |
| 2020-12-31 | $712.05 Million | +54.07% |
| 2019-12-31 | $462.15 Million | -10.85% |
| 2018-12-31 | $518.42 Million | -48.95% |
| 2017-12-31 | $1.02 Billion | +5.77% |
| 2016-12-31 | $960.04 Million | -3.28% |
| 2015-12-31 | $992.59 Million | +0.18% |
| 2014-12-31 | $990.84 Million | -3.34% |
| 2013-12-31 | $1.03 Billion | +5.28% |
| 2012-12-31 | $973.66 Million | +5.92% |
| 2011-12-31 | $919.22 Million | +7.20% |
| 2010-12-31 | $857.52 Million | +11.48% |
| 2009-12-31 | $769.18 Million | +10.66% |
| 2008-12-31 | $695.10 Million | +13.14% |
| 2007-12-31 | $614.36 Million | +12.22% |
| 2006-12-31 | $547.45 Million | +6.93% |
| 2005-12-31 | $512.00 Million | +11.24% |
| 2004-12-31 | $460.26 Million | +12.16% |
| 2003-12-31 | $410.36 Million | +51.18% |
| 2002-12-31 | $271.44 Million | -26.29% |
| 2001-12-31 | $368.24 Million | +6.81% |
| 2000-12-31 | $344.77 Million | +9.66% |
| 1999-12-31 | $314.40 Million | +7.27% |
| 1998-12-31 | $293.10 Million | +13.04% |
| 1997-12-31 | $259.30 Million | +6.97% |
| 1996-12-31 | $242.40 Million | +3.02% |
| 1995-12-31 | $235.30 Million | -8.12% |
| 1994-12-31 | $256.10 Million | +87.07% |
| 1993-12-31 | $136.90 Million | +17.31% |
| 1992-12-31 | $116.70 Million | +20.19% |
| 1991-12-31 | $97.10 Million | +14.24% |
| 1990-12-31 | $85.00 Million | +9.54% |
| 1989-12-31 | $77.60 Million | +0.52% |
| 1988-12-31 | $77.20 Million | +9.04% |
| 1987-12-31 | $70.80 Million | +73.11% |
| 1986-12-31 | $40.90 Million | +13.93% |
| 1985-12-31 | $35.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Accendra Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 71.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $6.02 Million | 1.07% |
| Common Stock | $154.40 Million | 27.32% |
| Other Comprehensive Income | $-49.34 Million | -8.73% |
| Other Components | $454.15 Million | 80.35% |
| Total Equity | $565.23 Million | 100.00% |
Accendra Health Inc Competitors by Market Cap
The table below lists competitors of Accendra Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Gillette Pakistan Ltd
KAR:GLPL
|
$24.00K |
|
TERAGO
BE:T2Q
|
$24.02K |
|
Feat Fund Investments Limited Partnership
TA:FEAT
|
$24.04K |
|
REVEZ CORPORATION LTD.
F:7IQ
|
$24.07K |
|
AJWA for Food Industries company Egypt
EGX:AJWA
|
$23.93K |
|
216400
KO:216400
|
$23.93K |
|
MORGAN ADV
BE:MGJ
|
$23.90K |
|
Fideicomiso Irrevocable No. F/3277 en Banco Invex, S. A. Institución de Banca Múltiple, INVEX Grupo
MX:EDUCA18
|
$23.85K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Accendra Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 924,166,000 to 565,226,000, a change of -358,940,000 (-38.8%).
- Net loss of 362,686,000 reduced equity.
- Other comprehensive income decreased equity by 17,526,000.
- Other factors increased equity by 21,272,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-362.69 Million | -64.17% |
| Other Comprehensive Income | $-17.53 Million | -3.1% |
| Other Changes | $21.27 Million | +3.76% |
| Total Change | $- | -38.84% |
Book Value vs Market Value Analysis
This analysis compares Accendra Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.33x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.96x to 0.33x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $1.23 | $2.42 | x |
| 1986-12-31 | $1.37 | $2.42 | x |
| 1987-12-31 | $1.69 | $2.42 | x |
| 1988-12-31 | $1.83 | $2.42 | x |
| 1989-12-31 | $1.84 | $2.42 | x |
| 1990-12-31 | $2.01 | $2.42 | x |
| 1991-12-31 | $2.23 | $2.42 | x |
| 1992-12-31 | $2.65 | $2.42 | x |
| 1993-12-31 | $3.00 | $2.42 | x |
| 1994-12-31 | $5.49 | $2.42 | x |
| 1995-12-31 | $5.06 | $2.42 | x |
| 1996-12-31 | $5.09 | $2.42 | x |
| 1997-12-31 | $5.43 | $2.42 | x |
| 1998-12-31 | $3.30 | $2.42 | x |
| 1999-12-31 | $3.56 | $2.42 | x |
| 2000-12-31 | $4.03 | $2.42 | x |
| 2001-12-31 | $4.65 | $2.42 | x |
| 2002-12-31 | $4.86 | $2.42 | x |
| 2003-12-31 | $7.24 | $2.42 | x |
| 2004-12-31 | $7.76 | $2.42 | x |
| 2005-12-31 | $8.53 | $2.42 | x |
| 2006-12-31 | $8.98 | $2.42 | x |
| 2007-12-31 | $10.08 | $2.42 | x |
| 2008-12-31 | $11.07 | $2.42 | x |
| 2009-12-31 | $12.39 | $2.42 | x |
| 2010-12-31 | $13.71 | $2.42 | x |
| 2011-12-31 | $14.61 | $2.42 | x |
| 2012-12-31 | $15.49 | $2.42 | x |
| 2013-12-31 | $16.36 | $2.42 | x |
| 2014-12-31 | $15.92 | $2.42 | x |
| 2015-12-31 | $15.98 | $2.42 | x |
| 2016-12-31 | $15.71 | $2.42 | x |
| 2017-12-31 | $16.92 | $2.42 | x |
| 2018-12-31 | $8.64 | $2.42 | x |
| 2019-12-31 | $7.63 | $2.42 | x |
| 2020-12-31 | $11.21 | $2.42 | x |
| 2021-12-31 | $12.43 | $2.42 | x |
| 2022-12-31 | $12.41 | $2.42 | x |
| 2023-12-31 | $12.19 | $2.42 | x |
| 2024-12-31 | $7.37 | $2.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Accendra Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -64.17%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.39%
- • Asset Turnover: 2.30x
- • Equity Multiplier: 8.24x
- Recent ROE (-64.17%) is below the historical average (5.49%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 12.26% | 1.20% | 3.79x | 2.70x | $810.00K |
| 1986 | 11.98% | 1.05% | 3.69x | 3.10x | $810.00K |
| 1987 | 9.18% | 1.13% | 3.74x | 2.18x | $-580.00K |
| 1988 | 10.88% | 1.15% | 3.85x | 2.46x | $680.00K |
| 1989 | 3.22% | 0.26% | 3.68x | 3.33x | $-5.26 Million |
| 1990 | 10.35% | 0.72% | 4.20x | 3.41x | $300.00K |
| 1991 | 12.46% | 1.18% | 3.30x | 3.21x | $2.39 Million |
| 1992 | 17.48% | 1.73% | 4.29x | 2.35x | $8.73 Million |
| 1993 | 14.68% | 1.44% | 4.18x | 2.44x | $6.41 Million |
| 1994 | 3.08% | 0.33% | 2.76x | 3.39x | $-17.71 Million |
| 1995 | -4.80% | -0.38% | 3.47x | 3.65x | $-34.83 Million |
| 1996 | 5.36% | 0.43% | 4.44x | 2.80x | $-11.24 Million |
| 1997 | 9.37% | 0.78% | 4.37x | 2.75x | $-1.63 Million |
| 1998 | 12.48% | 0.65% | 4.29x | 4.46x | $3.99 Million |
| 1999 | 15.35% | 0.88% | 3.68x | 4.74x | $9.76 Million |
| 2000 | 15.55% | 0.94% | 4.04x | 4.08x | $11.81 Million |
| 2001 | 9.75% | 0.60% | 4.00x | 4.04x | $-589.30K |
| 2002 | 17.41% | 1.19% | 3.92x | 3.72x | $20.12 Million |
| 2003 | 13.07% | 1.26% | 4.06x | 2.55x | $12.61 Million |
| 2004 | 13.14% | 1.34% | 4.00x | 2.46x | $14.47 Million |
| 2005 | 12.58% | 1.34% | 3.89x | 2.42x | $13.22 Million |
| 2006 | 8.91% | 0.88% | 3.28x | 3.08x | $-5.99 Million |
| 2007 | 11.84% | 1.07% | 4.49x | 2.47x | $11.27 Million |
| 2008 | 13.54% | 1.29% | 4.06x | 2.59x | $24.42 Million |
| 2009 | 13.61% | 1.30% | 4.60x | 2.27x | $27.74 Million |
| 2010 | 12.90% | 1.36% | 4.46x | 2.12x | $24.83 Million |
| 2011 | 12.53% | 1.34% | 4.43x | 2.12x | $23.28 Million |
| 2012 | 11.20% | 1.22% | 4.04x | 2.27x | $11.64 Million |
| 2013 | 10.82% | 1.22% | 3.90x | 2.27x | $8.38 Million |
| 2014 | 6.71% | 0.70% | 3.45x | 2.76x | $-32.58 Million |
| 2015 | 10.42% | 1.06% | 3.52x | 2.80x | $4.15 Million |
| 2016 | 11.33% | 1.12% | 3.58x | 2.83x | $12.78 Million |
| 2017 | 7.17% | 0.78% | 2.76x | 3.32x | $-28.75 Million |
| 2018 | -84.30% | -4.64% | 2.50x | 7.28x | $-488.85 Million |
| 2019 | -13.50% | -0.68% | 2.53x | 7.88x | $-108.59 Million |
| 2020 | 4.20% | 0.35% | 2.54x | 4.68x | $-41.33 Million |
| 2021 | 23.61% | 2.26% | 2.77x | 3.77x | $127.74 Million |
| 2022 | 2.37% | 0.22% | 1.85x | 5.70x | $-72.17 Million |
| 2023 | -4.47% | -0.40% | 2.03x | 5.51x | $-133.72 Million |
| 2024 | -64.17% | -3.39% | 2.30x | 8.24x | $-419.21 Million |
Industry Comparison
This section compares Accendra Health Inc's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,880,680,248
- Average return on equity (ROE) among peers: 10.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Accendra Health Inc (ACH) | $-429.51 Million | 12.26% | N/A | $24.00K |
| Arjo AB (publ) (ARRJF) | $9.30 Billion | 0.00% | 0.42x | $491.29 Million |
| Cardinal Health Inc (CAH) | $6.40 Billion | 18.22% | 3.07x | $51.10 Billion |
| Cencora Inc. (COR) | $166.30 Million | 40.59% | 11.39x | $64.39 Billion |
| Cosmos Health Inc. (COSM) | $-4.16 Million | 0.00% | 0.00x | $8.90 Million |
| EDAP TMS SA (EDAP) | $12.58 Million | -61.74% | 2.21x | $112.87 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $1.41 Million | 82.70% | 1.73x | $9.16 Million |
| Energy Management International Inc (ENMI) | $-365.00K | 0.00% | 0.00x | $383.13K |
| Exlites Holdings International Inc (EXHI) | $-126.29 | 0.00% | 0.00x | $574.58K |
| Galenica AG (GALNF) | $1.05 Billion | 16.35% | 1.14x | $3.75 Billion |